GlassScriptPhysician profile
Amber Ann Wallace
NPI 1104035526
$6,005.98
in general payments reported to CMS, 2019-2025
36 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $3,131 · 2021: $1,064 · 2022: $403 · 2023: $284 · 2024: $301 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,216.93 | 2019-2020 | |
| Coloplast Corp | $961.93 | 2021-2022 | |
| Abbvie INC. | $300.96 | 2019-2023 | |
| Pfizer INC. | $274.93 | 2019-2025 | |
| Astellas Pharma US INC | $189.86 | 2019-2025 | Veozah |
| Emd Serono, INC. | $87.64 | 2019 | |
| Coopersurgical, INC. | $79.39 | 2022-2025 | Paragard T 380a |
| Amgen INC. | $73.60 | 2019-2023 | Prolia, Evenity |
| Sage Therapeutics, LLC | $72.22 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $71.70 | 2021-2025 | Slynd |
| Organon LLC | $62.24 | 2022-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $61.47 | 2022 | |
| Daiichi Sankyo INC. | $49.69 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.61 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $37.53 | 2023-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $36.95 | 2019 | |
| Hologic Sales and Service, LLC | $32.20 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Therapeuticsmd, INC. | $30.60 | 2020 | |
| Sumitomo Pharma America, INC. | $29.64 | 2024 | Myfembree |
| Agile Therapeutics, INC. | $28.15 | 2021-2023 | Twirla |
| Supernus Pharmaceuticals, INC. | $23.47 | 2025 | Qelbree |
| Millicent US INC | $23.20 | 2025 | Intrarosa, Femring |
| Baxter Healthcare | $22.29 | 2022 | |
| Allergan, INC. | $20.92 | 2020 | |
| Minerva Surgical, INC | $17.79 | 2022 | |
| Optumhealth Care Solutions, LLC | $17.60 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Kci USA, INC. | $17.35 | 2020 | |
| Merck Sharp & Dohme LLC | $15.58 | 2022 | |
| Aspira Women'S Health INC | $15.54 | 2024 | Ova1 |
| Innovation Technologies INC | $14.73 | 2025 | Irrisept |
| Shield Therapeutics INC | $14.45 | 2025 | |
| Novo Nordisk INC | $13.57 | 2023 | Wegovy |
| Gynesonics, INC. | $12.81 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $12.01 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.35 | 2019 | |
| Lupin INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.